Clinical and economic outcomes of continuous glucose monitoring system (CGMS) in patients with diabetes mellitus: A systematic literature review

Aggarwal, A; Pathak, S.; Goyal, Richa

doi:10.1016/j.diabres.2022.109825

Cited by 18 publications

(54 citation statements)

References 51 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Further, recent advances in continuous glucose monitoring could potentially guide diet and activity choices for people with diabetes. Real-time monitoring of glucose levels—especially around times of eating, physical activity, sleep, and medication-taking—can help patients make good dietary and exercise choices for optimal glycemic control ( 61 ).…”

Section: Specific Recommendations and Discussionmentioning

confidence: 99%

The Transcultural Diabetes Nutrition Algorithm: A Middle Eastern Version

et al. 2022

View full text Add to dashboard Cite

Diabetes prevalence is on the rise in the Middle East. In countries of the Gulf region—Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, and the United Arab Emirates—prevalence rates are among the highest in the world. Further, Egypt now ranks as one of the top 10 countries in the world for high number of people with diabetes. Medical nutrition therapy is key to optimal management of diabetes. Patient adherence to nutritional guidance depends on advice that is tailored to regional foods and cultural practices. In 2012, international experts created a transcultural Diabetes Nutrition Algorithm (tDNA) for broad applicability. The objective of this current project was to adapt the algorithm and supportive materials to the Middle East region. A Task Force of regional and global experts in the fields of diabetes, obesity, and metabolic disorders met to achieve consensus on Middle East-specific adaptations to the tDNA. Recommendations, position statements, figures, and tables are presented here, representing conclusions of the tDNA-Middle Eastern (tDNA-ME) Task Force. Educational materials can be used to help healthcare professionals optimize nutritional care for patients with type 2 diabetes. The tDNA-ME version provides evidence-based guidance on how to meet patients' nutritional needs while following customs of people living in the Middle Eastern region.

show abstract

Section: Specific Recommendations and Discussionmentioning

confidence: 99%

The Transcultural Diabetes Nutrition Algorithm: A Middle Eastern Version

et al. 2022

View full text Add to dashboard Cite

show abstract

“…Of these potentially relevant articles, 69 publications were excluded for various reasons, and 7 publications met the inclusion criteria and were included in this report. These comprised 5 systematic reviews (SRs), [12][13][14][15][16] 1 randomized controlled trial (RCT), 17 and 1 economic evaluation. 18 Appendix 1 presents the PRISMA 19 flow chart of the study selection.…”

Section: Quantity Of Research Availablementioning

confidence: 99%

“…Five SRs, [12][13][14][15][16] 1 RCT, 17 and 1 economic evaluation 18 were included in this report. Three SRs 12,13,16 were published in 2022, and 2 14,15 were published in 2019. The RCT 17 was published in 2022, and the economic evaluation was published in 2018.…”

Section: Summary Of Study Characteristicsmentioning

confidence: 99%

“…18 All included SRs had broader inclusion criteria than the present review in terms of interventions of interest. All SRs [12][13][14][15][16] included studies on rtCGM as well as intermittent CGM or flash glucose monitoring. One SR was part of a larger review evaluating multiple interventions for diabetes.…”

Section: Summary Of Study Characteristicsmentioning

confidence: 99%

“…As for populations considered in the SRs, 3 of them had a broader scope than the present review. 12,13,16 They all included studies on patients with T1D, T2D, and gestational diabetes. 12,13,16 Additionally, 2 SRs had specific inclusion criteria regarding population.…”

Section: Summary Of Study Characteristicsmentioning

confidence: 99%

See 2 more Smart Citations

Real-Time Continuous Glucose Monitoring for People Living With Type 2 Diabetes

Subramonian¹,

Grobelna²

2022

cjht

View full text Add to dashboard Cite

The evidence regarding clinical and cost-effectiveness of real-time continuous glucose monitoring (rtCGM) compared to self-monitoring of blood glucose (SMBG) in patients with type 2 diabetes mellitus is summarized in this report. Results from 5 systematic reviews and 1 randomized controlled study suggest that in adult patients, rtCGM may be favoured over SMBG in improving glycated hemoglobin levels, and in lowering time with extreme low or high blood glucose levels. However, the evidence is uncertain due to limited quality evidence. In adults, limited safety evidence suggests that rtCGM is safe with low rates of adverse events. A cost-effectiveness analysis conducted in Spain found that rtCGM is not a cost-effective option compared to SMBG in adults with type 2 diabetes mellitus. No evidence was identified regarding clinical or cost-effectiveness of rtCGM in pediatric patients with type 2 diabetes mellitus.

show abstract